Skip to main content

Table 1 Antimicrobial Resistance in ESBL-producing E. coli from Blood (N = 15) and Urinary (N = 366)

From: Increasing prevalence of ESBL production among Irish clinical Enterobacteriaceae from 2004 to 2008: an observational study

 

Susceptible (%)

Intermediate (%)

Resistant (%)

 

Blood

Urine

Blood

Urine

Blood

Urine

Amikacin

11 (78.6)

312 (86.4)

2 (14)

29 (8.0)

1 (7.1)

20 (5.5)

Gentamicin

9 (60.0)

254 (70.2)

1 (7)

3 (0.8)

5 (33.3)

105 (29.0)

Ciprofloxacin

0 (0)

62 (17.0)

0 (0)

1 (0.3)

15 (100)

302 (82.7)

Meropenem

15 (100)

-

0 (0)

-

0 (0)

-

Trimethoprim

-

68 (18.6)

-

0 (0)

-

297 (81.4)

Nalidixic Acid

-

43 (11.8)

-

1 (0.3)

-

319 (87.9)

Nitrofurantoin

-

323 (88.5)

-

20 (5.5)

-

22 (6.0)

  1. Legend to Table 1. Susceptibility, Intermediate and Resistance to non-beta-lactam antimicrobial agents by Clinical Laboratory Standards Institute criteria for ESBL producing E. coli for the period July 2004 to December 2008. Note: one or more isolates had incomplete susceptibility data therefore the totals for each row do not fully correspond.
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us